Arcadia Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $1,306 | $1,255 | $1,170 | $1,597 |
Gross Profit | 673 | 435 | 500 | 495 |
EBITDA | -2,003 | -2,798 | -3,033 | -3,242 |
EBIT | -2,020 | -3,026 | -3,076 | -3,509 |
Net Income | 1,061 | -2,423 | -2,853 | -2,567 |
Net Change In Cash | 1,306 | 1,255 | 1,170 | 1,597 |
Free Cash Flow | -4,459 | -3,223 | -4,196 | -2,885 |
Cash | 5,504 | 3,317 | 6,518 | 10,611 |
Basic Shares | 1,362 | 1,361 | 1,285 | 1,359 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $5,330 | $9,956 | $6,780 | $8,034 |
Gross Profit | 2,030 | 154 | -1,928 | 2,835 |
EBITDA | -12,881 | -22,721 | -18,365 | -20,825 |
EBIT | -13,865 | -24,084 | -19,409 | -21,487 |
Net Income | -13,981 | -15,612 | -16,134 | -6,026 |
Net Change In Cash | 5,330 | 9,956 | 6,780 | 8,034 |
Cost of Revenue | 7,626 | |||
Free Cash Flow | -15,299 | -14,049 | -26,875 | -32,553 |
Cash | 6,518 | 20,644 | 28,685 | 14,042 |
Basic Shares | 1,236 | 599 | 532 | 248 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.78 |
2024-03-31 | -$1.78 |
2023-12-31 | -$2.52 |
2023-09-30 | -$1.44 |
